Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Dorcy Cancer Center Recognized for Patient-Centered Innovation and Care

Clinical and commercial leaders from GE Healthcare and Dorcy Cancer Center at St. Mary-Corwin Medical Center in Pueblo, Colorado, joined together today for a special tour to honor the Center’s continuing innovation in cancer care.

Disparities based on age, race persist in PET use for lung cancer patients

Demographic differences in the use of PET imaging among Medicare beneficiaries with non-small cell lung cancer have persisted since the modality’s approval by Medicare in 1998, according to a study published online Feb. 15 in Radiology.

Example of a mammogram showing X-ray images of both the right and left breast and patches of dense breast tissue.

ACR & SBI: Norwegian mammo overdiagnosis analysis flawed

The American College of Radiology (ACR) and the Society of Breast Imaging (SBI) have responded to a study in the Annals of Internal Medicine which concluded that 15 to 25 percent of cancers in the Norwegian mammography screening program are overdiagnosed, saying those overdiagnosis rates are overestimated, according to a statement on ACRs website.

The Future of Radiology

The present is big with the future, observed author Rudyard Kipling. The novelist was not referring to 21st century diagnostic imaging; however, the insight certainly applies.

Counseling increases mammo screening in low income populations

The most effective way to increase mammography screening among hard-to-reach, low-income, insured women is a stepwise intervention method or counseling program, according to a study published online June 29 in Cancer Epidemiology, Biomarkers & Prevention. The study found counseling increased screening compliance in the target population by 13.7 percent compared to the control group.

ASE: Biomarkers may predict chemo-related cardiotoxicity

According to research presented during the 21st annual scientific sessions of the American Society of Echocardiography (ASE) in San Diego this week, cardiac troponin plasma concentrations and longitudinal strain can predict the development of cardiotoxicity in patients treated with anthracyclines and trastuzumab chemotherapies.

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup